Awasthi, S., Ornelas, J., Armstrong, A., Johnson, J.A. and Eisen, D.B., 2021. Anogenital warts and relationship to child sexual abuse: Systematic review and meta‐analysis. Pediatric Dermatology, 38(4), pp.842-850.
Brisson, M., Kim, J.J., Canfell, K., Drolet, M., Gingras, G., Burger, E.A., Martin, D., Simms, K.T., Bénard, É., Boily, M.C. and Sy, S., 2020. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet, 395(10224), pp.575-590
Bogale, A.L., Belay, N.B., Medhin, G. and Ali, J.H., 2020. Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis. Virology Journal, 17(1), pp.1-15.
https://virologyj.biomedcentral.com/articles/10.1186/s12985-020-01448-1
Bosch, F.X., Lorincz, A., Muñoz, N., Meijer, C.J.L.M. and Shah, K.V., 2002. The causal relation between human papillomavirus and cervical cancer. Journal of clinical pathology, 55(4), pp.244-265. (NOT OA)
.Bruni L et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis.2010; (NOT OA)
Canfell K et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
https://www.sciencedirect.com/science/article/pii/S0140673620301574
Cervical cancer screening. IARC Handbooks of Cancer Prevention, Vol. 18. Lyon, International Agency for Research on Cancer, 2022
https://publications.iarc.fr/604
Clifford, G.M., Tully, S. and Franceschi, S., 2017. Carcinogenicity of human papillomavirus (HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer. Clinical Infectious Diseases, 64(9), pp.1228-1235. (NOT OA)
Demarco, M., Hyun, N., Carter-Pokras, O., Raine-Bennett, T.R., Cheung, L., Chen, X., Hammer, A., Campos, N., Kinney, W., Gage, J.C. and Befano, B., 2020. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. EClinicalMedicine, 22, p.100293.
https://www.sciencedirect.com/science/article/pii/S2589537020300377
de Martel, C., Georges, D., Bray, F., Ferlay, J. and Clifford, G.M., 2020. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. The Lancet Global Health, 8(2), pp.e180-e190.
https://www.sciencedirect.com/science/article/pii/S2214109X19304887
de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX; Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010 Nov;11(11):1048-56. (NOT OA)
Denny, L.A., Franceschi, S., de Sanjosé, S., Heard, I., Moscicki, A.B. and Palefsky, J., 2012. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine, 30, pp.F168-F174. (NOT OA)
Derkay, C.S., 2001. Recurrent respiratory papillomatosis. The Laryngoscope, 111(1), pp.57-69.
Efficacy, effectiveness and immunogenicity of one dose of HPV vaccine compared with no vaccination, two doses, or three doses. Cochrane Response March 2022
Farahmand M et al. Prevalence and genotype distribution of human papillomavirus infection in different anatomical sites among men who have sex with men: a systematic review and meta-analysis. Rev Med Virol.
https://onlinelibrary.wiley.com/doi/10.1002/rmv.2219
Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Piñeros, M., Znaor, A., Soerjomataram, I. and Bray, F., 2021. Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer; 2020.
https://gco.iarc.fr/today/home
Giuliano, A.R., Viscidi, R., Torres, B.N., Ingles, D.J., Sudenga, S.L., Villa, L.L., Baggio, M.L., Abrahamsen, M., Quiterio, M., Salmeron, J. and Lazcano-Ponce, E., 2015. Seroconversion following anal and genital HPV infection in men: the HIM study. Papillomavirus research, 1, pp.109-115.
https://www.sciencedirect.com/science/article/pii/S2405852115000130
Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020 https://www.who.int/initiatives/cervical-cancer-elimination-initiative#cms,
Guidance for the development of evidence-based vaccine-related recommendations. Geneva: World Health Organization; 2017
Human papillomavirus reference clones. Stockholm; International Human Papillomavirus
Reference Center
https://www.hpvcenter.se/human_reference_clones
Human papillomavirus vaccines: WHO position paper, May 2017. Weekly Epidemiological Record
https://www.who.int/publications/i/item/who-wer9219-241-268
Ibrahim Khalil, A., Mpunga, T., Wei, F., Baussano, I., de Martel, C., Bray, F., Stelzle, D., Dryden‐Peterson, S., Jaquet, A., Horner, M.J. and Awolude, O.A., 2022. Age‐specific burden of cervical cancer associated with HIV: a global analysis with a focus on sub‐Saharan Africa. International Journal of Cancer, 150(5), pp.761-772. (NOT OA)
Insinga, R.P., Dasbach, E.J., Elbasha, E.H., Liaw, K.L. and Barr, E., 2007. Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women. Infectious agents and cancer, 2, pp.1-10.
https://link.springer.com/article/10.1186/1750-9378-2-15
IARC monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses. Vol. 90. Lyon: International Agency for Research on Cancer
Introduction of HPV (human papillomavirus) vaccine. Geneva: World Health Organization
https://immunizationdata.who.int/pages/vaccine-intro-by-antigen/hpv.html?ISO_3_CODE=&YEAR=
Kelly, H., Weiss, H.A., Benavente, Y., de Sanjose, S., Mayaud, P., Qiao, Y.L., Feng, R.M., DeVuyst, H., Tenet, V., Jaquet, A. and Konopnicki, D., 2018. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. The lancet HIV, 5(1), pp.e45-e58.
https://www.sciencedirect.com/science/article/pii/S2352301817301492
List of prequalified vaccines. Geneva: World Health Organization
https://extranet.who.int/pqweb/vaccines/list-prequalified-vaccines
Man, I., Vänskä, S., Lehtinen, M. and Bogaards, J.A., 2021. Human papillomavirus genotype replacement: still too early to tell?. The Journal of infectious diseases, 224(3), pp.481-491.
https://academic.oup.com/jid/article/224/3/481/5716265
Marra, E., Lin, C. and Clifford, G.M., 2019. Type-specific anal human papillomavirus prevalence among men, according to sexual preference and HIV status: a systematic literature review and meta-analysis. The Journal of infectious diseases, 219(4), pp.590-598.
https://academic.oup.com/jid/article/219/4/590/5103515
Okoye, J.O., Ofodile, C.A., Adeleke, O.K. and Obioma, O., 2021. Prevalence of high-risk HPV genotypes in sub-Saharan Africa according to HIV status: a 20-year systematic review. Epidemiology and Health, 43.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510839/
Olsen, T.B., Munk, C., Christensen, J., Andersen, K.K. and Kjaer, S.K., 2014. Human papillomavirus prevalence among men in sub-Saharan Africa: a systematic review and emeta-analysis. Sexually transmitted infections, 90(6), pp.455-462. (NOT OA)
Patel, H., Wagner, M., Singhal, P. and Kothari, S., 2013. Systematic review of the incidence and prevalence of genital warts. BMC infectious diseases, 13, pp.1-14.
https://link.springer.com/article/10.1186/1471-2334-13-39
Recommendations to assure the quality, safety and efficacy of recombinant human papillomavirus virus-like particle vaccines. WHO Technical Report Series, No.999, Annex 4. Geneva: World Health Organization; 2016
https://www.who.int/publications/m/item/recombinant-hpv-like-particle-vaccines-annex-4-trs-no-999
Serrano, B., de Sanjosé, S., Tous, S., Quiros, B., Muñoz, N., Bosch, X. and Alemany, L., 2015. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. European Journal of Cancer, 51(13), pp.1732-1741. (NOT OA)
Strategic Advisory Group of Experts (SAGE) on Immunization
https://www.who.int/groups/strategic-advisory-group-of-experts-on-immunization
Sung H et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.
https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21660
Smith JS et al. Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health. 2011 (NOT OA)
Stanley, M.A., 2012. Epithelial cell responses to infection with human papillomavirus. Clinical microbiology reviews, 25(2), pp.215-222.
Stanley, M.A. and Sterling, J.C., 2014. Host responses to infection with human papillomavirus. Human Papillomavirus, 45, pp.58-74. (NOT OA)
Stelzle, D., Tanaka, L.F., Lee, K.K., Khalil, A.I., Baussano, I., Shah, A.S., McAllister, D.A., Gottlieb, S.L., Klug, S.J., Winkler, A.S. and Bray, F., 2021. Estimates of the global burden of cervical cancer associated with HIV. The Lancet Global Health, 9(2), pp.e161-e169.
https://www.sciencedirect.com/science/article/pii/S2214109X20304599
Tpw, J.G., Phipps, R.P. and Mandel, T.E., 1980. The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen‐binding dendritic cells as accessory cells. Immunological reviews, 53(1), pp.175-201. (NOT OA)
Unger, E.R., Fajman, N.N., Maloney, E.M., Onyekwuluje, J., Swan, D.C., Howard, L., Beck-Sague, C.M., Sawyer, M.K., Girardet, R.G., Sautter, R.L. and Hammerschlag, M.R., 2011. Anogenital human papillomavirus in sexually abused and nonabused children: a multicenter study. Pediatrics, 128(3), pp.e658-e665. (NOT OA)
Vardas, E., Giuliano, A.R., Goldstone, S., Palefsky, J.M., Moreira Jr, E.D., Penny, M.E., Aranda, C., Jessen, H., Moi, H., Ferris, D.G. and Liaw, K.L., 2011. External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. Journal of Infectious Diseases, 203(1), pp.58-65. (NOT OA)
Wei, F., Gaisa, M.M., D'Souza, G., Xia, N., Giuliano, A.R., Hawes, S.E., Gao, L., Cheng, S.H., Donà, M.G., Goldstone, S.E. and van der Loeff, M.F.S., 2021. Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies. The Lancet HIV, 8(9), pp.e531-e543.
https://www.sciencedirect.com/science/article/pii/S2352301821001089
Wingood, G.M., Seth, P., DiClemente, R.J. and Robinson, L.S., 2009. Association of sexual abuse with incident high-risk human papillomavirus infection among young African-American women. Sexually transmitted diseases, 36(12), p.784. (NOT OA)
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization; 2021.
https://www.who.int/publications/i/item/9789240030824
WHO vaccine position papers. Geneva: World Health Organization
WHO position paper process. Geneva: World Health Organization; 2020
https://www.who.int/publications/i/item/who-wer9750-645-672